Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali J Chakera

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Diabetes Care|December 25, 2012
Response to Comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834Ali J Chakera, Victoria L Carleton, Beverley Shields, et al.
Clinical Medicine (London, England)|February 3, 2017
Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictiveAli J Chakera, Timothy J McDonald, Bridget A Knight, et al.
Diabetes Care|February 20, 2014
The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohortAli J Chakera, Gill Spyer, Nicola Vincent, et al.
Diabetologia|October 5, 2013
Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemiaAmanda Stride, Beverley Shields, Olivia Gill-Carey, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 24, 2026
The impact of frailty on glycaemic control in older adults with type 1 diabetes: An observational studyJonathan A Golding, Scarlett O Long, Suzy V Hope, et al.
Diabetes Care|March 31, 2026
The Association Between Ambient Temperature and Hypoglycemia in People Living With Type 1 Diabetes: A Case Time Series Analysis Using Real-Time Continuous Glucose MonitoringHarriet E Daultrey, Nick S Oliver, Ali J Chakera, et al.
Diabetes Care|June 25, 2015
Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase MutationAli J Chakera, Anna M Steele, Anna L Gloyn, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 15, 2024
Type 1 diabetes and frailty: A scoping reviewJonathan A Golding, Esther S T Yong, Suzy V Hope, et al.
Diabetes Care|July 10, 2012
Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatmentAli J Chakera, Victoria L Carleton, Sian Ellard, et al.
Diabetologia|August 31, 2023
Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testingAlice E Hughes, Jayne A L Houghton, Benjamin Bunce, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Diabetes Care|December 25, 2012
Response to Comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834Ali J Chakera, Victoria L Carleton, Beverley Shields, et al.
Clinical Medicine (London, England)|February 3, 2017
Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictiveAli J Chakera, Timothy J McDonald, Bridget A Knight, et al.
Diabetes Care|February 20, 2014
The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohortAli J Chakera, Gill Spyer, Nicola Vincent, et al.
Diabetologia|October 5, 2013
Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemiaAmanda Stride, Beverley Shields, Olivia Gill-Carey, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 24, 2026
The impact of frailty on glycaemic control in older adults with type 1 diabetes: An observational studyJonathan A Golding, Scarlett O Long, Suzy V Hope, et al.
Diabetes Care|March 31, 2026
The Association Between Ambient Temperature and Hypoglycemia in People Living With Type 1 Diabetes: A Case Time Series Analysis Using Real-Time Continuous Glucose MonitoringHarriet E Daultrey, Nick S Oliver, Ali J Chakera, et al.
Diabetes Care|June 25, 2015
Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase MutationAli J Chakera, Anna M Steele, Anna L Gloyn, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 15, 2024
Type 1 diabetes and frailty: A scoping reviewJonathan A Golding, Esther S T Yong, Suzy V Hope, et al.
Diabetes Care|July 10, 2012
Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatmentAli J Chakera, Victoria L Carleton, Sian Ellard, et al.
Diabetologia|August 31, 2023
Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testingAlice E Hughes, Jayne A L Houghton, Benjamin Bunce, et al.
Pageof 3